Patheon API Inc. has applied to the Drug Enforcement Administration to register as a bulk manufacturer of several controlled substances. The registration would allow the company to import these substances as reference standards for research and development in its API Manufacturing operations. Interested parties, including current registered bulk manufacturers, can submit comments or objections electronically by April 21, 2025, and may also request a hearing on the application by the same date. Comments submitted will be tracked, and successful submissions will receive a Comment Tracking Number.
Simple Explanation
Patheon API Inc. wants permission to make special medicines, and people can share their thoughts about it until April 21, 2025. They need to let an official group called the Drug Enforcement Administration know what they think and follow some rules to do so.